Attached files
| file | filename |
|---|---|
| 10-Q - ZIOPHARM ONCOLOGY INC | v191647_10q.htm |
| EX-99.1 - ZIOPHARM ONCOLOGY INC | v191647_ex99-1.htm |
| EX-31.1 - ZIOPHARM ONCOLOGY INC | v191647_ex31-1.htm |
| EX-31.2 - ZIOPHARM ONCOLOGY INC | v191647_ex31-2.htm |
| EX-16.1 - ZIOPHARM ONCOLOGY INC | v191647_ex16-1.htm |
EXHIBIT
32.1
CERTIFICATION
In
connection with the Quarterly Report on Form 10-Q of ZIOPHARM Oncology, Inc.
(the “Company”) for the period ended June 30, 2010, as filed with the Securities
and Exchange Commission on the date hereof (the “Report”), we Jonathan Lewis,
the Principal Executive Officer of the Company and Richard E. Bagley, the
Principal Financial and Accounting Officer of the Company, hereby certify,
pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, that, to our knowledge:
|
(1)
|
the
Report fully complies with the requirements of Section 13(a) or 15(d), as
applicable, of the Securities Exchange Act of 1934, as amended,
and
|
|
(2)
|
the
information in the Report fairly presents, in all material respects, the
financial condition and results of operations of the
Company.
|
Dated:
July 30, 2010
|
/s/ Jonathan Lewis
|
|
|
Jonathan
Lewis, M.D., Ph.D.
|
|
|
Chief
Executive Officer
|
|
|
(Principal
Executive Officer)
|
Dated:
July 30, 2010
|
/s/ Richard E. Bagley
|
|
|
Richard
E. Bagley
|
|
|
President
and Chief Financial Officer
|
|
|
(Principal
Financial and Accounting Officer)
|